CTNM
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ: CTNM · HEALTHCARE · BIOTECHNOLOGY
$12.82
+6.48% today
Updated 2026-04-30
Market cap
$463.34M
P/E ratio
—
P/S ratio
11.15x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$3 – $16
Volume
0.3M
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-26.27M | $-20.12M | $19.35M | $-32.84M | $-55.31M |
| Capital expenditures | $168000.00 | $118000.00 | $414000.00 | $514000.00 | $231000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $1.75M | $1.93M | $2.22M | $6.80M | $10.04M |
| Free cash flow | $-26.43M | $-20.24M | $18.93M | $-33.36M | $-55.54M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |